Among the isolated populations from primary prostate cancers, only CD44+ CD133+ cells display in vitro self-renewal [4,9,10] and express core stem cell genes OCT4, NANOG, SOX2, nestin, and c-kit [4,20]. This evidence concerns the gene CD44 and prostate cancer.